Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luke B Snell

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
American Journal of Respiratory and Critical Care Medicine|November 8, 2023
Routine Metagenomics Service for ICU Patients with Respiratory InfectionThemoula Charalampous, Adela Alcolea-Medina, Luke B Snell, et al.
The Lancet. Infectious Diseases|May 27, 2022
Clinical features and management of human monkeypox: a retrospective observational study in the UKHugh Adler, Susan Gould, Paul Hine, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 17, 2021
Combined epidemiological and genomic analysis of nosocomial SARS-CoV-2 infection early in the pandemic and the role of unidentified cases in transmissionLuke B Snell, Chloe L Fisher, Usman Taj, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 27, 2022
Detection of SARS-CoV-2 variants by Abbott molecular, antigen, and serological testsMary A Rodgers, Ana Olivo, Barbara J Harris, et al.
Nature Microbiology|October 16, 2021
Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concernLiane Dupont, Luke B Snell, Carl Graham, et al.
Medrxiv : the Preprint Server for Health Sciences|June 15, 2021
Antibody longevity and cross-neutralizing activity following SARS-CoV-2 wave 1 and B.1.1.7 infectionsLiane Dupont, Luke B Snell, Carl Graham, et al.
Nature Microbiology|October 27, 2020
Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humansJeffrey Seow, Carl Graham, Blair Merrick, et al.
Elife|September 13, 2022
Effectiveness of rapid SARS-CoV-2 genome sequencing in supporting infection control for hospital-onset COVID-19 infection: Multicentre, prospective studyOliver Stirrup, James Blackstone, Fiona Mapp, et al.
The Journal of Infection|October 5, 2021
The Alpha variant was not associated with excess nosocomial SARS-CoV-2 infection in a multi-centre UK hospital studyFlorencia A T Boshier, Cristina Venturini, Oliver Stirrup, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
American Journal of Respiratory and Critical Care Medicine|November 8, 2023
Routine Metagenomics Service for ICU Patients with Respiratory InfectionThemoula Charalampous, Adela Alcolea-Medina, Luke B Snell, et al.
The Lancet. Infectious Diseases|May 27, 2022
Clinical features and management of human monkeypox: a retrospective observational study in the UKHugh Adler, Susan Gould, Paul Hine, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 17, 2021
Combined epidemiological and genomic analysis of nosocomial SARS-CoV-2 infection early in the pandemic and the role of unidentified cases in transmissionLuke B Snell, Chloe L Fisher, Usman Taj, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 27, 2022
Detection of SARS-CoV-2 variants by Abbott molecular, antigen, and serological testsMary A Rodgers, Ana Olivo, Barbara J Harris, et al.
Nature Microbiology|October 16, 2021
Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concernLiane Dupont, Luke B Snell, Carl Graham, et al.
Medrxiv : the Preprint Server for Health Sciences|June 15, 2021
Antibody longevity and cross-neutralizing activity following SARS-CoV-2 wave 1 and B.1.1.7 infectionsLiane Dupont, Luke B Snell, Carl Graham, et al.
Nature Microbiology|October 27, 2020
Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humansJeffrey Seow, Carl Graham, Blair Merrick, et al.
Elife|September 13, 2022
Effectiveness of rapid SARS-CoV-2 genome sequencing in supporting infection control for hospital-onset COVID-19 infection: Multicentre, prospective studyOliver Stirrup, James Blackstone, Fiona Mapp, et al.
The Journal of Infection|October 5, 2021
The Alpha variant was not associated with excess nosocomial SARS-CoV-2 infection in a multi-centre UK hospital studyFlorencia A T Boshier, Cristina Venturini, Oliver Stirrup, et al.
Pageof 4